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Dopamine perturbation of gene co-
expression networks reveals differential
response in schizophrenia for translational
machinery
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Pablo V. Gejman2,3 and Harald H. H. Göring1, MGSP. V. Gejman6, A. R. Sanders6, J. Duan6, D. F. Levinson7, J. Shi8,
N. G. Buccola9, B. J. Mowry10, R. Freedman11, A. Olincy11, F. Amin12, D. W. Black13, J. M. Silverman14, W. F. Byerley15,
C. R. Cloninger16 and D. M. Svrakic16
Abstract
The dopaminergic hypothesis of schizophrenia (SZ) postulates that positive symptoms of SZ, in particular psychosis,
are due to disturbed neurotransmission via the dopamine (DA) receptor D2 (DRD2). However, DA is a reactive
molecule that yields various oxidative species, and thus has important non-receptor-mediated effects, with empirical
evidence of cellular toxicity and neurodegeneration. Here we examine non-receptor-mediated effects of DA on gene
co-expression networks and its potential role in SZ pathology. Transcriptomic profiles were measured by RNA-seq in B-
cell transformed lymphoblastoid cell lines from 514 SZ cases and 690 controls, both before and after exposure to DA
ex vivo (100 μM). Gene co-expression modules were identified using Weighted Gene Co-expression Network Analysis
for both baseline and DA-stimulated conditions, with each module characterized for biological function and tested for
association with SZ status and SNPs from a genome-wide panel. We identified seven co-expression modules under
baseline, of which six were preserved in DA-stimulated data. One module shows significantly increased association
with SZ after DA perturbation (baseline: P= 0.023; DA-stimulated: P= 7.8 × 10-5; ΔAIC=−10.5) and is highly enriched
for genes related to ribosomal proteins and translation (FDR= 4 × 10−141), mitochondrial oxidative phosphorylation,
and neurodegeneration. SNP association testing revealed tentative QTLs underlying module co-expression, notably at
FASTKD2 (top P= 2.8 × 10−6), a gene involved in mitochondrial translation. These results substantiate the role of
translational machinery in SZ pathogenesis, providing insights into a possible dopaminergic mechanism disrupting
mitochondrial function, and demonstrates the utility of disease-relevant functional perturbation in the study of
complex genetic etiologies.
Introduction
Schizophrenia (SZ) is a disabling mental disorder
characterized by severe disturbances in thought, behavior,
and emotion, including psychotic symptoms and cognitive
impairment1. Affecting approximately 1% of individuals
globally2, SZ is heritable and highly polygenic3, with a
number of neurobiological pathways tentatively impli-
cated in its etiology. The dopaminergic hypothesis is a
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longstanding SZ model, attributing positive symptoms of
the disorder, in particular psychosis, to dysregulation in
dopaminergic neurotransmission via the dopamine (DA)
receptor D2 (DRD2). This is supported by effects of
psychotogenic stimulants (e.g., amphetamines) that acti-
vate DA receptors, as in vivo brain imaging studies have
shown that amphetamine-induced increases in DA
response are correlated with positive symptoms of SZ4,5.
Moreover, it is well documented that antipsychotic drugs
(e.g., chlorpromazine, haloperidol) block DRD2, with
clinical response linked to receptor occupancy6. Meta-
analysis of brain imaging data have shown increased post-
synaptic DRD2 density in the striatum of SZ patients, but
the relationship is complicated by the absence of sig-
nificant differences between drug-naïve patients and
controls, suggesting that the DRD2 upregulation may be
due to antipsychotic treatment7. Results from genome-
wide association studies (GWAS) do show an association
between common variants at the DRD2 locus and SZ8,
supporting the contention that D2 receptor variants affect
SZ risk.
The action of DA on post-synaptic receptors represents
one of the final steps of dopaminergic neurotransmission.
A number of studies, however, have identified the most
evident dopaminergic abnormality in SZ as being pre-
synaptic and likely non-receptor-mediated, related to DA
synthesis capacity, baseline synaptic DA levels, and/or DA
release. Elevated pre-synaptic striatal DA levels have
emerged as a fairly robust feature of SZ7,9–11, with
increases also observed in the prodromal phase of the
disorder that is linked to symptom severity and onset of
psychosis12. In contrast, recent topographic analyses of
extra-striatal brain regions have revealed DA deficits in
the dorsolateral prefrontal cortex (DLPFC), with hypo-
function associated with the activation of working mem-
ory in this region13. With current drug treatments
primarily acting upon the same mechanism, namely D2/
D3 receptor blockade, future research and drug develop-
ment for SZ is needed to better target pre-synaptic DA
abnormalities.
The molecular pathways linking aberrant DA levels to
SZ etiology are not well understood. In addition to
synaptic transmission, DA is known to have oxidative
mechanisms that lead to apoptosis, a process that con-
tributes to DA neuron loss in Parkinson’s disease (PD)
and other neurodegenerative disorders14,15. Experimental
studies provide a potential means of identifying such
pathogenic pathways, without confounding due to drug
treatment and other factors. Towards this end, we
recently investigated non-receptor-mediated effects of DA
on cellular gene expression in B-cell transformed lym-
phoblastoid cell lines (LCLs) and SZ risk. Using a cell
perturbation approach ex vivo, we measured tran-
scriptomic profiles by RNA sequencing (RNAseq) before
and after exposure to DA in LCLs from SZ cases and
controls, revealing differentially expressed genes enriched
for brain expression and for functions related to immunity
and apoptosis16. In this paper, we expand upon this work
by examining differences in co-expression patterns (i.e.,
joint changes in gene behavior) due to DA stimulation.
Such network-based approaches offer a means of clus-
tering correlations in the transcriptome that tend to be
biologically meaningful and can reveal insights into the
larger genetic architecture of complex disorders. Using
weighted gene co-expression network analysis, we suc-
cessfully identified a co-expression module present at
both baseline and in the DA-stimulated data, and whose
association with SZ varies as a function of DA, with
heightened disease correlation upon DA perturbation.
This module is highly enriched for ribosomal proteins, as
well as for genes implicated in neurodegenerative dis-
orders, providing potential insights into non-receptor-
mediated effects of DA in SZ pathogenesis.
Materials and methods
Samples
The RNAseq sample consists of 514 SZ cases and 690
controls after quality control (QC) processing (total
sample= 1204), as previously described16. The subjects
are of European ancestry and represent a subset of the
Molecular Genetics of Schizophrenia (MGS) collection
selected for GWAS and analyses of CNVs and tran-
scriptomics16–20. There are 639 males (263 cases and 376
controls) and 565 females (251 cases and 314 controls) in
this sample, with study enrollment ages ranging from 15
to 84 years, with detailed phenotypic data available17,21.
Cases are severely affected on average, with most (~98%)
exhibiting positive, psychotic symptoms (i.e., delusions,
hallucinations). The NorthShore University HealthSystem
Institutional Review Board approved this study, with
informed consent obtained from all subjects.
Cell culture and DA perturbation
LCLs for the study sample were obtained from the
Rutgers University Cell and DNA Repository22, for which
we measured EBV load, viable cell count, and ATP level at
cell harvest, all known to have an effect on gene expres-
sion23. For the design of the DA perturbation model,
different DA concentrations were tested in a pilot study of
four LCLs from control subjects16. At 100 μM, significant
changes were observed for gene expression throughout
the genome, affecting approximately 13% of genes, with
only limited effects on LCL growth (reduction by ~20%),
and thus 100 μM was selected for DA perturbation of the
larger study sample. Cells were grown in independent
wells in the presence or absence of DA, with DA exposure
lasting 24 h. For comparison, in vivo DA concentrations
in the human striatum, a brain region associated with
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dopaminergic abnormalities in SZ, is highly varied, with
DA levels ranging from nM to μM concentrations, with
significant differences between tonic DA release into
extra-synaptic spaces (i.e., background activity) and the
more transient and intense phasic activation that occurs
in the synapses, with interactions between the two
mechanisms [Grace, 1991]. Our ex vivo model represents
a steady-state of DA exposure, albeit an extreme one, with
an intended focus on pre-synaptic and non-receptor-
mediated DA effects.
RNAseq and data processing
RNA sequencing was performed for baseline and DA-
stimulated samples at the University of Minnesota
Genomics Center on an Illumina HiSeq2000 at approxi-
mately 10 million reads per sample, with RNA quality
scores indicative of high quality. Resulting RNAseq data
were processed as previously described16,20,24. Alignment
of 50-bp single reads to the Gencode v. 20 (GRCh38)
human genome reference assembly was achieved with
Tophat v. 2.0.5. Gene expression levels were calculated as
reads per kilobase (kb) of transcript, per million mapped
reads (RPKM) for the exon model of the longest transcript
of a gene, with each quantile-normalized to account for
batch biases and log2 transformed for variation stabili-
zation. QC of gene RPKM levels, as previously described
in detail16, involved several steps, including analysis of
technical and biological replicates (i.e., same RNA and
independent cell cultures of same LCL sample), con-
sistency of sex chromosome gene expressions versus
reported sex, comparison of RNAseq-called genotypes
with previous GWAS SNP genotypes17,18, comparison of
sample completion rate between cases and controls for
each gene at baseline or DA-stimulation conditions, and
identification of expression outliers based on PCA. QC
processing yielded gene expression data for 21,043 genes
for both baseline and DA-stimulated conditions. For
downstream analyses, log2 transformed RPKM expression
levels were residualized for the following relevant cov-
ariates: sex, age, cell counts and ATP levels at cell harvest
under the two respective conditions, genotypic ancestry
PCs 1–5, Epstein-Barr virus load, and sequencing batch.
The variance in gene expression explained by these bio-
logical and technical confounds are presented in Supple-
mentary Figures 1 and 2, with non-significant differences
observed in the overall variance estimates for the baseline
and DA-stimulated data sets (s2baseline= 4.20; s
2
DA= 4.18;
P= 0.48).
Weighted gene co-expression network analysis (WGCNA)
To identify correlation patterns in the expression data
for baseline and DA-stimulated conditions, WGCNA was
performed using the R package of the same name
(WGCNA v. 3.3.3)25. The WGCNA pipeline is as follows:
(1) Using the command “pickSoftThreshold”, we assessed
whether gene expression data have “scale-free topology”
(i.e., frequency distribution of k, which is the summation
of pairwise correlation coefficients for each gene, follows a
power law) and identified values of the exponential
parameter β for achieving it. A transformation such as this
down-weights weaker correlations between genes,
resulting in more cohesive co-expression networks that
are centered on and stabilized by highly connected “hub
genes”, which the authors of this approach argue are
robust to random changes in connection patterns and
more closely resemble true biology26. (2) Adjacency
matrices were computed for each data set (i.e., baseline
and DA-stimulation), representing pairwise correlation
coefficients (i.e., Pearson’s r) transformed by the afore-
mentioned β to ensure a scale-free correlation structure.
We employed the unsigned method, in which absolute
values of the coefficients were transformed, thus avoiding
ablation of any strongly negative co-expression relation-
ships (note: we also performed WGCNA based on signed
adjacency matrices, in order to investigate the robustness
of our identified modules and their associations with SZ).
(3) From the adjacency matrices, topological overlap
matrices (TOMs) were computed, representing the
“interconnectedness” between pairs of genes, both
directly, as well as indirectly, with connection strengths
mediated by shared gene neighbors that are one-step
away, which reportedly achieves more cohesive and bio-
logically meaningful modules than ones determined solely
from direct correlations27. These values were then used to
calculate a dissimilarity distance measure, DistTOM,
equating to 1—TOM. (4) We constructed dendrograms
for the 21,043 genes with available gene expression data
based on hierarchical clustering of DistTOM scores. This
was achieved using the well-established UPGMA method
via the R command “hclust”. Modules of co-expressed
genes were then determined from branches in the
resulting dendrograms using the command “cutreeDy-
namic”, which performs adaptive branch pruning based
on various criteria, including a minimum cluster size of 50
genes and a conservative branch cut height of 0.99. The
Partitioning Around Medoids option, which is a greedy
algorithm for identifying outlying genes for module
inclusion, was not utilized in order to maintain cohesive
modules within the dendrograms. With these particular
settings, modules of highly correlated genes will be pre-
ferentially detected, with the larger number of genes
exhibiting weaker network connectivities left unassigned,
including potential risk genes. (5) Module eigengenes
(ME) were computed for each subject, which simply
represent the first principal component of expression
levels of genes assigned to a particular module28. ME
scores were then used to calculate pairwise correlations
between modules, as well as with SZ status, which in turn
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were used to generate dissimilarity distance matrices
(DistME) by subtracting the coefficients from one and
construct dendrograms via UPGMA. A distance threshold
of 0.25 was used to identify closely related modules, which
were then merged, necessitating the recalculation of MEs
for final module assignments.
WGCNA results were visualized through a combination
of dendrograms and heatmaps (R commands “TOMplot”
and “plotEigengeneNetworks”), as well as network topol-
ogies comprised of gene nodes and edges (i.e., gene-gene
connection strengths from the adjacency matrices;
threshold= 0.01) that were constructed in Cytoscape v.
3.6.029. Significance of gene overlap between modules
across the two conditions was determined through pair-
wise hypergeometric testing of 2 × 2 contingency tables
(i.e., Fisher’s exact test). Modules were originally assigned
random color names, which were subsequently changed
such that modules with significant overlap have matching
color names, in an effort to simplify for the reader the
downstream analyses that compare WGCNA results
across the two conditions.
Association between WGCNA modules and SZ
The relationships of the baseline modules to SZ status
(i.e., case or control) were examined through logistic
regression analysis of the respective ME scores in R v.
3.3.2 (note: no other covariates were included since gene
expression data were residualized; see above), as well as
for recomputed MEs based on the DA-stimulated data for
the same set of module genes. Association results for the
two sets of MEs were compared, with goodness-of-fit
assessed by differences in Akaike Information Criteria
(ΔAIC) for the DA-stimulated and baseline models (note:
due to multicollinearity, multiple regression models that
include both MEs were not examined). Moreover, we
calculated the proportion of genes in each module that
have been linked to SZ risk in the large GWAS conducted
by the SZ Working Group of the Psychiatric Genomics
Consortium (PGC)8. The 108 SNPs and indels that dis-
played genome-wide significance in the PGC study were
assigned to 1308 genes, including non-protein coding
RNAs, using a 250 K bp window around the loci in the
GRCh38 reference assembly, with the significance of the
enrichments determined via permutations (10,000×)
weighted by total gene connectivity scores (k) from the
adjacency matrices.
Preservation of WGCNA modules
How well the baseline modules were preserved under
DA-stimulation (and vice versa) was assessed in the
WGCNA program through various statistics related to
module density and connectivity in the two data sets30,
including correlations of: intramodular connectivity
(kIM), which is the summation of adjacency matrix values,
or connection strengths, of a module gene with other
module genes; and eigengene-based connectivity (kME),
representing the correlation of gene expression profiles
with MEs of a given module. To summarize the different
preservation metrics, a composite statistic based on
median rank was computed for each module. The kIM
scores were also used to screen for so-called “hub genes”,
highly connected nodes that may represent key drivers in
the co-expression modules.
Gene set enrichment analysis
To identify classes of genes or biological features that
are over-represented in our WGCNA modules, we per-
formed enrichment analyses for gene lists defined by GO-
terms (molecular functions and biological processes) and
KEGG pathways using the online tool DAVID v. 6.831,
relative to the total set of genes comprising our expression
data. Significance of gene enrichment was evaluated using
a modified, and more conservative, Fisher’s Exact P-value,
as well as false discovery rate (FDR). In addition, we
employed the functional annotation clustering algorithm
available in DAVID, which accounts for the redundant
nature of gene annotations, and reports groups of related
annotation terms from across various bioinformatics
databases, yielding enrichment scores representing the
geometric means of Fisher’s Exact P-values for individual
gene sets tested in the primary analyses.
Genome-wide association testing
We screened the genome for quantitative trait loci
(QTL) influencing co-expression patterns of select
WGCNA modules. Genotype association testing was
performed on ME scores in PLINK v. 1.07 via linear
regression32, which included the first five principal com-
ponents as covariates to control for potential population
substructure. The genotype data were generated on the
Affymetrix 6.0 array, with 671,422 SNPs passing QC fil-
tering, as previously described17. In addition, we tested for
SNP*SZ interaction in the linear model in an effort to
identify QTL effects that are modified by case-control
status (i.e., comparing the SNP regression coefficients of
the two groups).
Results
WGCNA modules
While we have previously identified a large number of
genes whose expression level response to DA perturbation
varies between LCLs from SZ cases compared to ones
from unaffected individuals16, the interpretation of these
transcriptome-wide results are complex. We therefore
employed an alternative analytical approach, one that
focuses on gene co-expression networks—and thus pre-
sumably biology—to potentially yield additional insights.
The first step in WGCNA was to evaluate the scale-free
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topology of our gene expression data sets. This is char-
acterized by a correlation structure in the data that is
comprised of highly connected hub genes, with relatively
weaker pairwise correlations outside the hubs. Neither the
baseline nor the DA-stimulated data are scale-free
according to the WGCNA standard, which is the norm
for gene expression studies. Thus, the baseline and DA
data sets needed to be transformed for the adjacency
matrices by down-weighting weaker correlations, with the
β parameter set to 8 and 10, respectively, to achieve an
r2 ≥ 0.9 with the scale-free model. Given our interest in
the changes in gene expression in response to DA-
stimulation (and whether it varies between SZ cases and
controls), we also evaluated differential expression levels
between the two conditions (i.e., response to DA pertur-
bation), which were the target phenotype of a previous
paper reporting on transcriptomic signatures of SZ by our
research group16. However, the response data are not
scale-free, and we failed to achieve robust fits to the scale-
free model when transformed under a series of β powers
(ranging from 1 to 20) for the total sample, as well as for
SZ cases and controls separately. The authors of the
WGCNA approach recommend against using such dif-
ferential data, as it alters gene-gene co-expression struc-
ture and leads to single, highly correlated networks,
invalidating the scale-free assumption. Thus, we per-
formed WGCNA on the baseline and DA-stimulated data
sets separately, and then compared the resulting modules.
For the baseline data, 13 co-expression modules were
initially identified, each randomly assigned to a color
(Supplementary Figure 3), which were reduced to seven
after merging modules with similar expression profiles
(DistME < 0.25). The sizes of the seven modules range
from 74 to 521 genes, with mean intramodular k values
ranging from 1.17 to 8.61 (overall mean of 5.44), indi-
cating that the identified modules comprise of highly
intercorrelated genes. Most of the genes in the dataset are
unassigned (n= 19,366), labeled as “grey”. As is evident
from the deep branching in the dendrogram and the
corresponding red highlights in the heatmap in Fig. 1a,
the brown and blue modules exhibit the strongest gene-
gene interconnectedness based on TOM dissimilarity
distances. When comparing modules based on their
eigengene profiles (Fig. 1b), the black and green modules
show the strongest connections between one another
(DistME= 0.39), sharing a clade with the green-yellow
and magenta modules. To better visualize the gene co-
expressions beyond what are represented in these binary-
tree hierarchies, we constructed a two-dimensional net-
work topology in Cytoscape v. 3.6.0 (Fig. 1c). With a
minimum threshold of 0.01 for gene-gene connection
strength, the purple module emerges as an outlier, with
only a small number of network edges paired with black
nodes. Overall, the network shows where connections are
most concentrated (e.g., between the brown and black
modules) and where they are not (e.g., between the brown
and blue modules).
For the DA-stimulated data, seven co-expression mod-
ules were initially identified (Supplementary Figure 4),
which were reduced to six after merging of two similar
modules. The six modules range from 62 to 198 genes.
Relative to the baseline results, the number of unassigned
genes (n= 20,401) increased by 1,035 genes, perhaps
indicating transcriptome-wide disruption in co-
Fig. 1 a Heatmap of pairwise TOM scores, aligned with the relevant dendrogram branches, of genes assigned to the seven baseline modules.
b Correlation heatmap and dendrogram of eigengene profiles for baseline modules (including SZ status). c Two-dimensional network of gene-gene
connection strengths (adjacency matrix values; minimum of 0.01) created in Cytoscape v. 3.6.0. Node colors correspond to baseline modules to which
the genes were assigned. Top results from gene enrichment analyses of GO-terms and KEGG pathways are also shown, with Fisher’s Exact P-values in
parentheses
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expression patterns upon DA exposure of the LCLs. To
understand how these modules relate to the ones gener-
ated in the baseline data, we performed pairwise hyper-
geometric testing across the two sets, thus identifying
modules that show significant overlap in gene member-
ship (Table 1). All six DA-stimulated modules were found
to have substantial and exclusive overlap with a baseline
module, ranging from 86.9% to all of the genes being
shared. Similar to the baseline, the brown DA-stimulated
module displays the strongest connectivity in the gene
heatmap, harboring the deepest branches in the corre-
sponding dendrogram (Fig. 2a). The black and green
modules again were closest in their co-expression levels
(Fig. 2b; DistME= 0.46), which is evident in the Cytos-
cape network (Fig. 2c), with most of the edges positioned
between these two modules.
Given the significant overlap in the genes comprising
the baseline and DA-stimulated modules, it is perhaps not
surprising that the gene-gene interconnectedness of the
baseline modules is well preserved in the DA-stimulated
expression data (Supplementary Table 1), with strong
correlations in both kIM, ranging from 0.78 to 0.99, and
kME, ranging from 0.82 to 0.99 (excluding the purple
module outlier). Moreover, for three of the six matching
modules, the same hub genes are identified based on the
top kIM scores (Supplementary Table 2): RPL11 for the
brown modules; HNF1b for the black modules; and
NFKB2 for the green modules. The median ranks of the
various preservation statistics from the WGCNA program
indicate that the brown module is the best preserved of
the seven baseline modules in the DA-stimulated data,
and vice versa.
Table 1 Overlap between baseline and DA-stimulated WGCNA modules
Module color No. genes—baseline No. genes—DA-stimulated Overlap (%)a P-valueb
Black 521 198 97.5 3.4 × 10−322
Blue 270 99 100.0 0c
Brown 194 111 99.1 6.2 × 10−244
Green 127 62 95.2 6.9 × 10−138
Green-Yellow 264 107 86.9 2.1 × 10−171
Magenta 227 65 90.8 3.4 × 10−115
Purpled 74 – – –
aPercent of genes in the DA module that overlaps with genes in the respective baseline module
bP-values based on the hypergeometric test, as computed by the R command “overlapTableUsingKME” in the WGCNA package
cHypergeometric P-value too small to be estimated
dAll 74 genes in the purple baseline module were unassigned in the WGCNA results for the DA-stimulated data
Fig. 2 a Heatmap of pairwise TOM scores, aligned with the relevant dendrogram branches, of genes assigned to the six DA-stimulated modules.
b Correlation heatmap and dendrogram of eigengene profiles for DA-stimulated modules (including SZ status). c Two-dimensional network of gene-
gene connection strengths (adjacency matrix values; minimum of 0.01) created in Cytoscape v. 3.6.0. Node colors correspond to DA-stimulated
modules to which the genes were assigned. Top results from gene enrichment analyses of GO-terms and KEGG pathways are also shown, with
Fisher’s Exact P-values in parentheses
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Gene set enrichment analyses
To investigate the potential biological relevance of the
WGCNA modules, we performed gene set enrichment
analyses for GO-terms and KEGG pathways in DAVID
(Table 2). For both the baseline and DA-stimulated
results, highly significant, replicated enrichments were
observed in the pair of matching brown modules: GO-
term “SRP-dependent co-translational protein targeting
to membrane”, representing 42.3% and 70.6% of the genes,
respectively (FDR= 4.0 × 10−141 and 2.7 × 10−161); and
KEGG pathway “Ribosome”, representing 40.7% and
68.8% of the same genes (FDR= 2.3 × 10−110 and 1.1 ×
10−125). This is also reflected in the functional annotation
clustering of the entire enrichment results (Supplemen-
tary Table 3), as the brown modules produced the highest
overall scores in each data set for terms related to ribo-
somal translation. Some of the other top enrichments that
were observed in both matching modules include: KEGG
pathway “Protein processing in endoplasmic reticulum”
for the blue modules; GO-term “Inflammatory response”
for the green modules; KEGG pathway “Cell cycle” and
GO-term “Cell division” for the green-yellow modules;
and GO-term “Poly(A) RNA binding” for the magenta
modules. Among the top enrichment results that are not
shared, most remain highly enriched in the alternate
module but are simply not the top hit (e.g., TNF signaling
is the second highest enriched KEGG pathway in the DA-
stimulated green module; FDR= 4.0 × 10−8). Although
DA-stimulation does appear to have broadly weakened
the top enrichment signals observed in the baseline
modules, some dramatically (e.g., GO-term “Defense
response to virus” in the black modules, with the baseline
FDR of 5.2 × 10−17 becoming a non-significant 0.59), with
the exceptions being the GO-term “Cell division” for the
green-yellow modules and the top results from the brown
modules.
Associations with SZ
The gene network modules were initially identified and
subsequently characterized using the entire gene expres-
sion data sets, without taking SZ status into account.
Thus, to determine whether the co-expression levels of a
module differ between cases and controls, ME scores for
the baseline modules (proportion of the variation
explained ranging from 0.48 to 0.57) were tested for
association with SZ (Table 3). With the exception of the
Table 2 Top gene set enrichment for WGCNA modules
Module Top KEGG pathway FDR Top GO-terma FDR
Baseline
Black hsa05162: Measles 2.0 × 10−8 0051607: Defense response to virus 5.2 × 10−17
Blue hsa04141: Protein processing in ER 5.4 × 10−66 0006888: ER to Golgi vesicle transport 5.3 × 10−30
Brown hsa03010: Ribosomeb 2.3 × 10−110 0006614: SRP protein targeting to ERc 4.0 × 10−141
Green hsa04668: TNF signaling 9.6 × 10−12 0006954: Inflammatory response 9.7 × 10−9
Green-Yellow hsa04110: Cell cycle 1.2 × 10−20 0051301: Cell division 1.2 × 10−32
Magenta hsa03008: Ribosome biogenesis 4.3 × 10−12 0044822: Poly(A) RNA binding 1.5 × 10−72
Purple hsa04960: Sodium reabsorption 0.63 0005201: Extracellular matrix structure 0.18
DA-stimulated
Black hsa04961: Endocrinal calcium reabsorption 0.014 0007165: Signal transduction 0.011
Blue hsa04141: Protein processing in ER 3.1 × 10−48 0036498: IRE1-mediated protein response 4.4 × 10−21
Brown hsa03010: Ribosome 1.1 × 10−125 0006614: SRP protein targeting to ER 2.7 × 10−161
Green hsa04064: NF-kappa B signaling 4.1 × 10−8 0006954: Inflammatory response 6.4 × 10−6
Green-Yellow hsa04110: Cell cycle 1.3 × 10−14 0051301: Cell division 1.2 × 10−44
Magenta hsa04612: Antigen processing 0.037 0044822: Poly(A) RNA binding 2.6 × 10−24
aTested GO-terms related to biological processes and molecular functions in DAVID v. 6.8
bGenes from the brown baseline module belonging to this pathway (n= 80): MRPL33, MRPL34, MRPS21, RPL10, RPL10A, RPL11, RPL12, RPL13, RPL13A, RPL14, RPL15,
RPL17, RPL18, RPL18A, RPL19, RPL21, RPL22, RPL22L1, RPL23, RPL23A, RPL24, RPL26, RPL27, RPL27A, RPL28, RPL29, RPL3, RPL30, RPL31, RPL32, RPL34, RPL35, RPL35A,
RPL36, RPL36A, RPL37, RPL37A, RPL38, RPL39, RPL4, RPL41, RPL5, RPL6, RPL7, RPL7A, RPL8, RPL9, RPLP0, RPLP1, RPLP2, RPS10, RPS11, RPS12, RPS13, RPS14, RPS15,
RPS15A, RPS16, RPS18, RPS19, RPS2, RPS20, RPS21, RPS23, RPS24, RPS25, RPS27, RPS27A, RPS28, RPS29, RPS3, RPS3A, RPS4X, RPS5, RPS6, RPS7, RPS8, RPS9, RPSA, and
UBA52
cGenes from the brown baseline module belonging to this GO-term (n= 77): RPL10, RPL10A, RPL11, RPL12, RPL13, RPL13A, RPL14, RPL15, RPL17, RPL18, RPL18A,
RPL19, RPL21, RPL22, RPL23, RPL23A, RPL24, RPL26, RPL27, RPL27A, RPL28, RPL29, RPL3, RPL30, RPL31, RPL32, RPL34, RPL35, RPL35A, RPL36, RPL36A, RPL37, RPL37A,
RPL38, RPL39, RPL4, RPL41, RPL5, RPL6, RPL7, RPL7A, RPL8, RPL9, RPLP0, RPLP1, RPLP2, RPS10, RPS11, RPS12, RPS13, RPS14, RPS15, RPS15A, RPS16, RPS18, RPS19, RPS2,
RPS20, RPS21, RPS23, RPS24, RPS25, RPS27, RPS27A, RPS28, RPS29, RPS3, RPS3A, RPS4X, RPS5, RPS6, RPS7, RPS8, RPS9, RPSA, SRP14, and UBA52
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green-yellow (P= 0.11) and brown modules (P= 0.023),
the gene co-expressions of the baseline modules show
highly significant associations with SZ (P < 10−5), with the
green module, which is enriched for genes related to
inflammatory response (see above), having the most sig-
nificant result (P < 2.0 × 10−16). This is in general agree-
ment with our previous report which found a vast number
of genes to be differentially expressed between cases and
controls at baseline16. To investigate the impact of DA-
stimulation on these findings, we recomputed the MEs
using the DA-stimulated expression data for the exact
same sets of module genes (accounting for 0.42–0.52 of
the variation), and then retested the associations. In other
words, we compared our two conditions by generating
respective pairs of co-expression profiles for each baseline
module and thus fixed for gene membership. For six of
the modules, less significant associations were observed,
reflected by decreases in the estimated regression coeffi-
cients. The lone exception is the brown module (enriched
for translational machinery), for which the P-value
decreased from 0.023 to 7.8 × 10−5, corresponding to an
increase in absolute effect size from −1.12 ± 0.96 to
−1.95 ± 0.96 (Z= 1.19; P= 0.11). This module is also the
only one exhibiting greater goodness-of-fit between SZ
and its DA-stimulated MEs (ΔAIC=−10.5), representing
approximately 190-fold increase in model likelihood33. As
one would expect, similar association results were
observed for MEs from the matching DA-stimulated
modules (Supplementary Table 4). Notably, 4.1% of the
genes in the brown module are located within 250 K bp of
the 108 SZ risk loci reported by the PGC8, which is the
highest percentage among the seven modules, and
represents near significant enrichment relative to the 2.5%
observed for unassigned genes in the baseline data set
(empirical P= 0.079).
Signed WGCNA networks
The modules reported here are based on unsigned
networks, which incorporate negative correlations
between genes. To determine how this potentially
impacted our network construction (i.e., TOM calcula-
tions) and association test results, we re-ran WGCNA
using a signed adjacency matrix for the baseline data. All
seven of the original baseline modules were found to have
matching modules from the signed network, with highly
significant overlaps in gene memberships (P < 1.9 ×
10−163), and each corresponding to the same top enrich-
ments in GO-terms and KEGG pathways (e.g., brown
module: SRP-dependent co-translational protein target-
ing, FDR= 3.6 × 10−117; and ribosome, FDR= 5.5 ×
10−105), except for the purple module. Moreover, the
matching green module from the signed network is again
the most strongly associated with SZ (P < 2.0 × 10−16), and
similarly the brown module is the only one exhibiting a
marked increase in association upon DA-stimulation,
producing an identical ΔAIC of -10.5, which is again a
stark outlier among all the other identified modules
(ΔAIC ranges from −0.4 to 21). All of this underscores
the robustness of our key findings.
QTLs for the brown module
Given that the brown module is the only module that
exhibits stronger association with SZ upon DA-stimula-
tion, with preserved connectivity patterns and gene
enrichment profile from the baseline condition, we
scanned its co-expression levels for QTLs, representing
Table 3 Associations between baseline co-expression modules and SZ
DA-stimulated dataa
Baseline module Beta (SE) P-value Beta (SE) P-value ΔAICb % PGC locic
Black 3.30 (0.49) 1.7 × 10−11 3.00 (0.49) 9.8 × 10−10 7.9 2.7
Blue −3.07 (0.49) 4.1 × 10−10 −2.63 (0.49) 8.7 × 10−8 10.4 1.1
Brown −1.12 (0.49) 0.023 −1.95 (0.49) 7.8 × 10−5 −10.5 4.1
Green 4.46 (0.48) <2.0 × 10−16 3.95 (0.49) 6.0 × 10−16 18.4 1.6
Green-Yellow 0.78 (0.49) 0.11 0.092 (0.49) 0.85 2.5 2.7
Magenta 2.29 (0.49) 3.4 × 10−6 0.98 (0.49) 0.048 17.7 4.0
Purple −2.55 (0.49) 2.3 × 10−7 −2.16 (0.49) 1.2 × 10−5 7.7 0
Grey (Unassigned) 3.24 (0.49) 4.3 × 10−11 2.44 (0.49) 7.2 × 10−7 18.9 2.5
aFor the baseline WGCNA modules, eigengenes were recalculated based on the DA-stimulated gene expression data, which were then tested for association with SZ
status
bDifference in Akaike Information Criteria (AIC) values for the DA-stimulated and baseline regression models
cPercentage of SZ risk genes in a given module. This is based on the findings of the PGC GWAS on SZ, in which 108 SNPs and indels were identified as genome-wide
significant, which were assigned to genes and ncRNAs using a 250 K bp window around the loci. The percentage of unassigned genes that are PGC risk genes (as
defined above) is 2.5%
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genetic “drivers” of regulatory systems that may underlie
the architecture of transcriptional patterns (e.g., tran-
scription factors, non-coding RNAs (ncRNAs), feedback
mechanisms), by testing its ME scores for association with
genome-wide SNP data (n= 671,423) available for the
study sample. The top-5 association results for the brown
module under DA-stimulation are presented in Table 4,
with the MEs accounting for 64% of the variation. None
achieved genome-wide significance (FDR= 0.35; genomic
inflation factor λ= 1.0), with the top SNP, rs6504934 (P
= 2.7 × 10−6), located upstream (~18 kb) of a long non-
coding RNA (lncRNA), RN7SKP14. For the other four
SNPs listed in the table, all are in close proximity and
exhibit strong LD (pairwise r2 > 0.87), located within or
near FASTKD2. This gene encodes a pro-apoptotic pro-
tein that is required for mitochondrial ribosome assem-
bly34,35, and has been associated with memory
performance and hippocampal structure36.
We also tested for interaction between SNP genotypes
and case-control status on co-expression scores in order
to assess whether QTL effects vary as a function of SZ
under DA-stimulation. The top-5 SNP*SZ interaction
effects are given in Table 5 (note: results for the baseline
data are available in Supplementary Table 5). Again, none
achieved genome-wide significance (FDR= 0.18; λ=
0.99). The top SNP, rs10497316 (P= 3.8 × 10−7), is loca-
ted in the gene XIRP2, which encodes an actin-binding
protein, and does not show evidence of association with
SZ in the PGC GWAS results, although strong enrich-
ment of rare loss-of-function (LoF) mutations in XIRP2
were observed among SZ cases in a recent whole-exome
sequence study37. For the other SNPs listed in the table,
they are located either within or closest to lncRNA genes,
with three in near-perfect LD (pairwise r2 > 0.99), and all
four showing nominal evidence of association with SZ in
the PGC data (P-values ranging from 0.050 to 0.0043).
Discussion
With the rapid expansion of transcriptome sequencing
over the past decade, researchers have increasingly
focused on the expression of genes relative to each other
(i.e., co-expression) as a means of assigning putative
functions to genes and ncRNAs based on the annotations
of wider co-expression networks (so-called “guilt-by-
association”), as well as gaining insight into potential
regulatory relationships that underlie biological processes.
Such network-based approaches reduce the inherent
complexity and dimensionality of genome-wide expres-
sion data, as most genes are weakly correlated with other
genes and thus disregarded, depending on chosen
Table 4 Top-5 genome-wide SNP associations with brown module eigengenes for dopamine-stimulated data
SNP Chrom. Position (bp)a MAb Gene/ncRNA (Distance) Beta (SE) Pc
rs6504934 17 54,752,745 A RN7SKP14 (18 kb) 0.0057 (0.0012) 2.7 × 10−6
rs17280449 2 206,821,737 T FASTKD2 −0.0090 (0.0019) 2.8 × 10−6
rs6726245 2 206,814,503 A FASTKD2 −0.0090 (0.0019) 2.8 × 10−6
rs16838820 2 206,755,606 C MDH1B; FASTKD2 (10 kb) −0.0093 (0.0020) 3.1 × 10−6
rs6435351 2 206,794,290 C FASTKD2 −0.0093 (0.0020) 3.3 × 10−6
aBased on human reference assembly GRCh38.p7
bMinor allele
cFor the P-values presented here, FDR (Benjamini-Hochberg method)= 0.35
Table 5 Top-5 Genome-wide SNP × SZ interactions for brown module eigengenes for dopamine-stimulated data
SNP Chrom. Position (bp)a MAb Gene/ncRNA (Distance) Beta (SE) PSNP
a
SZ
c PPGC
d
rs10497316 2 167,121,310 T XIRP2e 0.020 (0.0039) 3.8 × 10−7 0.98
rs17076524 6 146,985,464 T STXBP5-AS1 0.018 (0.0036) 9.6 × 10−7 0.050
rs764113 7 109,040,240 A AC004014.3 (88 kb) −0.012 (0.0026) 1.8 × 10−6 0.0043
rs12540954 7 109,047,522 T AC004014.3 (95 kb) −0.012 (0.0026) 1.9 × 10−6 0.0050
rs10953591 7 109,048,681 C AC004014.3 (96 kb) −0.012 (0.0026) 2.7 × 10−6 0.0048
aBased on human reference assembly GRCh38.p7
bMinor allele
cFor the P-values presented here, FDR (Benjamini-Hochberg method)= 0.18
dGWAS P-values for SZ status as reported by the SZ Working Group of the Psychiatric Genomics Consortium (PGC), involving up to 36,989 SZ cases and 113,075
controls8
eIn a recent gene-based association study of rare loss-of-function variants conducted by UK10K Consortium on whole-exome sequences of 4264 SZ cases, 9343
controls, and 1077 trios, the gene XIRP2 yielded the strongest association with SZ status (P= 3.5 × 10−5)37
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thresholds. Moreover, co-expression analyses have been
used to identify novel risk genes for various human dis-
eases, including psychiatric disorders, as coordinated gene
expression is critical for brain development and function.
This includes SZ, for which studies of postmortem brain
specimens and peripheral blood have found dysregulated
gene networks, including modules enriched for genes
involved in synaptic transmission38, immune func-
tion39,40, oxidative stress and mitochondria41,42, and
neurogenesis and neuron differentiation42,43.
In our network analysis of the genome-wide effects of
DA perturbation on gene expression in LCLs, we
examined the total sample, comprising both SZ cases
and controls. Prior studies of the brain transcriptome
have found gene co-expression patterns to be organized
into distinct cellular and functional categories44, with
significant overlap observed in gene membership of
case- and control-only modules, suggesting that module
composition and gene-gene connectivity per se are not
likely to be key determinants in the pathogenesis of
SZ42, although this does not preclude the possibility of
certain regulatory relationships between smaller num-
bers of genes. Thus, our aim was to identify changes in
co-expression levels within our networks that are
associated with SZ status, to which one module, related
to ribosomal translation, has revealed a marked
increase in disease risk upon DA-stimulation in our
sample.
Based on WGCNA, we identified six co-expression
modules under baseline conditions that are preserved
under DA-stimulation, both in terms of gene-gene net-
work connectivities and significant overlap in gene
membership with corresponding modules generated from
the DA-stimulated data. When tested for their association
with SZ status, the co-expression profiles (i.e., eigengenes)
of the green baseline module (n= 127 genes) show the
strongest effect, which is reflected by its median FDR of
1.1 × 10−9 for the genes within the module when analyzed
individually in prior gene-based association results16. This
module has a significant enrichment of genes related to
inflammatory response, in particular TNF signaling and
NF-kappa B signaling—cytokine pathways that are
involved in systemic inflammation, apoptosis, immune
response, and synaptic plasticity, with substantial evi-
dence implicating them in the pathophysiology of SZ45–48.
Under DA-stimulation, the corresponding module (n=
62 genes) also produced the most significant association
with SZ, with the same pattern of primary enrichment for
genes involved in inflammation and NF-kappa B and TNF
signaling. These results are consistent with our previous
studies on these expression data16,20,22, which found
immune-related genes enriched among both baseline and
DA-stimulated transcripts that are differentially expressed
by affection status, as well as transcriptome studies by
other groups49, thus further supporting the immune and
cytokine hypothesis for SZ.
Overall, five of the seven baseline modules are strongly
associated with SZ (P < 10−5), both for the baseline and
DA-stimulated data, with the co-expression profiles of the
unassigned genes also exhibiting a highly significant
association (P= 4.3 × 10−11). This is consistent with our
gene-based results, which showed a large number of SZ-
associated gene expressions under both conditions (31
and 21%, respectively; FDR < 0.05). As previously dis-
cussed16, we did not find any evidence that these results
are a consequence of any technical artifacts, and thus
assume that they reflect real biology in our well-controlled
LCL study. Intriguingly, this may reflect the recently
proposed “omnigenic” model50, where most, if not all,
genes outside core disease-related pathways indirectly
contribute to disease risk, especially for transcriptomics
and regulatory networks that involve higher-order, inter-
connected structures.
DA-stimulated effects related to translational machinery
Of the six co-expression modules that correspond
across the two conditions, only the brown module (n=
194 genes at baseline) shows stronger evidence of asso-
ciation with SZ after DA perturbation, with the estimated
effect changing from −1.12 ± 0.96 (P= 0.023) to a highly
significant −1.95 ± 0.96 (P= 7.8 × 10−5), with the latter
representing a substantial 190-fold increase in model
likelihood. Moreover, eight of the baseline module genes
(4.1%) are in proximity to the 108 significant GWAS loci
reported by the PGC for SZ, the highest proportion
observed among our modules (empirical P= 0.079), seven
of which are downregulated and exhibit more significant
associations with SZ after DA-stimulation (top FDR=
1.7 × 10−4): MRPS21, NDUFB3, NFATC3, RBX1, RPL13A,
RPS11, SRP14, and ZFAS1. Despite cellular stress and
transcriptome-wide changes caused by the DA perturba-
tion of the LCLs (~91% of genes responsive to DA at FDR
< 0.05)16, gene-gene connectivity patterns in the brown
module are strongly preserved in the DA-stimulated
expression data (see Supplementary Table 1).
For the brown module under both conditions, but
especially DA-stimulation, highly significant enrichments
were observed for genes involved in signal recognition
particle (SRP)-dependent targeting for endoplasmic reti-
culum (ER) translation (~134-fold; FDR= 2.7 × 10−161)
and ribosomal translation (~43-fold; FDR= 1.1 × 10−125),
accounting for 67.6 and 69.4% of the module genes,
respectively. Coupled with the increased association with
SZ under DA conditions, these results for the brown
module are compelling, as ribosomal proteins and the
broader translational machinery have been implicated in
neurodevelopment and SZ in a number of recent papers.
A gene knockdown study in the rat forebrain found
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neuronal maturation to be associated with a considerable
expansion of ribosomal proteins, with translational
insufficiency impairing dendritic growth and neuronal
connectivity51. In another study involving human stem
cell-derived neural progenitor cells from SZ patients and
controls52, increased levels of global protein synthesis and
translational machinery, including ribosomal proteins,
were observed in the SZ cells. In contrast, for human
olfactory neurosphere-derived cells, discovery-based pro-
teomics and functional analyses revealed significant
reductions in particular ribosomal proteins among SZ
patients, including total ribosomal signal intensity53. And,
perhaps most intriguingly, Zhou et al54. reveal that the
interactome of ZNF804A, a SZ risk gene robustly repli-
cated in different populations55–58, is highly represented
by ribosomal and mitochondrial proteins, with ZNF804A
modulating translational efficiency. Moreover, the ribo-
somal protein RPSA interacts with ZNF804A, and rescues
neuronal migration and translational defects caused by
knockdown of the ZNF804A homolog in mice, linking the
SZ risk gene to neurodevelopment and translational
control. Although ZNF804A was not assigned to our
brown modules, RPSA was for both baseline and DA-
stimulated data, and interestingly, the DA-stimulated
expression levels of RPSA show a significant negative
correlation with SZ (FDR= 3.9 × 10−6), with its differ-
ential expression between the two conditions (i.e., DA
response) yielding the top association result among the
110 overlapping module genes (FDR= 0.027)16.
Links to mitochondrial function?
Although we were unable to identify genome-wide
significant QTLs for the brown module under DA-sti-
mulation, the top results are nonetheless of interest. In
particular, FASTKD2 harbors a linkage disequilibrium
block of strongly associated SNPs (minimum P= 2.8 ×
10−6), with the gene playing a critical role in the bio-
genesis of mitochondrial ribosomes and translation34,35.
The encoded RNA-binding protein modulates apoptosis,
and is involved in the assembly of mitochondrial RNA
granules, often induced under conditions of cellular
stress, with abnormal accumulation of such granules
linked to some neurodegenerative disorders59,60. Inter-
estingly, the top enrichment result for the brown module,
SRP-dependent targeting for ER translation, serves as a
mechanism for mRNA to escape stress granule seques-
tration through localization to the ER61, which has
obvious implications for neuronal cell survival. Further-
more, a SNP within FASTKD2, rs7594645, has been pre-
viously linked to memory performance in older adults,
with carriers exhibiting neuroprotective effects, including
increased hippocampal volume and gray matter density,
and decreased cerebrospinal fluid levels of apoptotic
mediators, all of which are features of Alzheimer’s
disease36. And in a pair of interactome studies based on
affinity capture-mass spectrometry62,63, FASTKD2 was
identified as a protein-protein interaction partner of
NGRN, a SZ risk gene with downstream effects on
ZNF804A in the aforementioned work by Zhou et al.54, as
part of a larger oxidative phosphorylation (OXPHOS)
network regulating mitochondrial translation.
For SNP*SZ interactions on DA-stimulated co-expres-
sion, rs10497316 in XIRP2 was our top finding for the
brown module (P= 3.8 × 10−7), reflecting a marked dif-
ference in the magnitude and direction of its main effect
among SZ cases (β= 0.013 ± 0.0030; P= 6.77 × 10−6)
versus controls (β=−0.0063 ± 0.0050; P= 0.014). The
gene encodes a protein that protects actin filaments from
depolymerization and is involved in neuronal integrity. In
a large whole-exome sequencing study by the UK10K
Consortium37, a disproportionately high number of LoF
mutations was reported for XIRP2 among SZ cases, cor-
responding to its top gene-based association for this class
of variants (P= 3.5 × 10−5). Moreover, XIRP is a known
target of MEF2A64,65, a DNA-binding transcription factor
that mediates neuronal differentiation and survival, as it is
cleaved by mitochondrial apoptotic caspases during
excitotoxic neuronal stress66, and XIRP2 has previously
shown decreased expression in brain samples of PD
patients67. For the other top interaction effects listed in
Table 5, the SNPs all show nominal association with SZ in
the PGC data (P < 0.05), and are positioned within or
closest to lncRNAs, an abundant class of RNA molecules
that regulate gene expression and are believed to play a
critical role in neuronal development68, with prior co-
expression network analyses implicating them in early
onset SZ69.
Taken together, these SNP association results for the
brown module suggest potential links with mitochondrial
processes and cell survival/apoptosis, in particular neu-
rodegeneration, as impaired ribosome production has
been documented in neurodegenerative diseases70–72.
This is borne out in our enrichment analyses for the
KEGG lists in the baseline module (Fig. 1c; see Supple-
mentary Table 6), as the next most enriched pathways
after ribosomes are genes related to: OXPHOS in mito-
chondria (FDR= 2.4 × 10−15); Huntington’s disease (FDR
= 9.0 × 10−14); Parkinson’s disease (FDR= 1.2 × 10−12);
and Alzheimer’s disease (FDR= 3.9 × 10−12). For the DA-
stimulated module, however, all four of these failed to
show significant enrichment (minimum FDR= 0.20),
stemming from the non-inclusion of 21 genes belonging
to these pathways, 16 of which are shared. Taking a closer
look at this splinter group, we found the association of its
eigengenes with SZ status to change in a manner similar
to the larger brown module (ΔAIC=−6.6), going from a
non-significant association at baseline (β=−0.70 ± 0.94;
P= 0.16) to a significant one (β=−1.44 ± 0.94;
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P= 3.50 × 10−3), with DA-stimulation weakening the co-
expression between genes from this subgroup and the rest
of the brown module, as evidenced by pairwise correla-
tions in their eigengene scores (baseline: r= 0.81 ± 0.018;
DA-stimulation: r= 0.69 ± 0.029).
Mitochondrial dysfunction characterizes various neu-
rodegenerative diseases, reflected by the gene enrich-
ments of the aforementioned KEGG pathways.
Mitochondria play key roles in ATP generation, reactive
oxygen species formation, and apoptosis, with neurons
particularly dependent on mitochondria because of their
high energy demands, and thus susceptible to cellular
damage due to oxidative stress73. What is more, impaired
mitochondrial function and variants in related genes have
been repeatedly implicated in SZ74–76, with prior co-
expression network analyses of SZ reporting similar
modular enrichments39,41,69. SZ cases have been shown to
exhibit abnormal mitochondrial respiration77, increased
oxidative stress78, and altered gene expression of mito-
chondrialcomplexes79. Remarkably, in a recent study of
pyramidal neurons from the DLPFC of postmortem SZ
subjects, significant transcriptome alterations were iden-
tified in molecular pathways related to mitochondrial
energy production and the regulation of protein transla-
tion, which corroborates our main findings80. These
alterations of nuclear-encoded genes involved in energy
production are consistent with the poor activation of
DLPFC circuitry during increased cognitive demands that
has been long observed in SZ81. Moreover, subjects
responsive to antipsychotic treatment were identified in
another study as having approximately a 40% decrease in
the number of mitochondria per synapse in dorsal stria-
tum at postmortem, with treatment-resistant cases having
normal levels82, thus suggesting that there may be a bio-
logical distinction between treatment response and
treatment resistance in SZ, for which DA may represent a
key trigger. DA has been shown to have non-receptor-
mediated effects on mitochondrial function, along with
antipsychotics, as it inhibits Complex I activity and ATP
production of the respiratory chain through its uptake
into the organelle83-86. This potential link between DA
and mitochondrial dysfunction in SZ risk is compelling
and, given our findings, warrants further investigation.
Conclusion
The results of our study identify a co-expression net-
work that exhibits increased risk for SZ upon DA-
stimulation of LCLs, highly enriched for ribosomal pro-
teins and translational machinery. This suggests that
relevant but cryptic pathological mechanisms underlying
SZ can become detectable by functional perturbation,
which makes replication of these findings more involved
given our unique study design. Moreover, the use of LCLs
as a cellular model versus brain presents some clear
limitations for our study of a presumably brain-related
disorder, as expression of some genes in LCLs will sub-
stantially differ from that in brain, although most
expression signatures are shared between different tis-
sues87–91. However, LCLs also have distinct advantages, as
they are derived from the most accessible tissue, yielding
sizeable samples, and allow for experimental manipula-
tions such as DA perturbation, as we have discussed
previously in greater detail16. Nonetheless, our findings
provide key insights into the long-standing dopaminergic
hypothesis for SZ based on gene co-expression changes,
revealing non-receptor-mediated DA disturbances in
translational machinery and mitochondrial function,
including genes involved in neurodegeneration, with
potential treatment targets of pre-synaptic dopaminergic
features commonly observed in the disorder.
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